A carregar...
Comparative evaluation of Latanoprostene Bunod, Timolol Maleate, and latanoprost Ophthalmic Solutions to assess their safety and efficacy in lowering intraocular pressure for the management of Open-Angle Glaucoma
OBJECTIVES: Timolol maleate has been reported to be a safer intraocular pressure (IOP) lowering treatment than latanoprost. The United States Food and Drug Administration approved latanoprostene bunod, a nitric oxide-donating prodrug of latanoprost, for lowering IOP. This study compared the safety a...
Na minha lista:
| Publicado no: | Clinics (Sao Paulo) |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Faculdade de Medicina / USP
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7688071/ https://ncbi.nlm.nih.gov/pubmed/33263632 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6061/clinics/2020/e1874 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|